Hikma Pharmaceuticals Plc Director/PDMR Shareholding (8074M)
13 Maggio 2020 - 2:28PM
UK Regulatory
TIDMHIK
RNS Number : 8074M
Hikma Pharmaceuticals Plc
13 May 2020
Hikma Pharmaceuticals PLC
Notification and public disclosure of transactions by persons
discharging managerial responsibilities
Said Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Said Darwazah
2 Reason for the notification
a) Position/status Executive Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Liquidation of HMS Holdings SAL resulting in
transaction the disposal of 1,350,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals PLC.
HMS Holdings SAL is defined as a Person Closely
Associated with the Executive Chairman, who
is a shareholder.
c) Price(s) and Price(s): GBP24.50p
volume(s) Volume(s): 1,350,000
d) Aggregated information Aggregated volume: 1,350,000
Price: GBP24.50p
e) Date of the transaction 13 May 2020
f) Place of the London
transaction
Mazen Darwazah
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Mazen Darwazah
2 Reason for the notification
a) Position/status Executive Vice Chairman
b) Initial notification Initial notification
/Amendment
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name Hikma Pharmaceuticals PLC
b) LEI 549300BNS685UXH4JI75
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of Description: Ordinary shares of 10 pence each
the financial ID Code: GB00B0LCW083
instrument, type
of instrument
and identification
code
b) Nature of the Liquidation of HMS Holdings SAL resulting in
transaction the disposal of 1,350,000 Ordinary Shares of
10 pence each in Hikma Pharmaceuticals PLC.
HMS Holdings SAL is defined as a Person Closely
Associated with the Executive Vice Chairman,
who is a shareholder.
c) Price(s) and Price(s): GBP24.50p
volume(s) Volume(s): 1,350,000
d) Aggregated information Aggregated volume: 1,350,000
Price: GBP24.50p
e) Date of the transaction 13 May 2020
f) Place of the London
transaction
Peter Speirs
Company Secretary, responsible for releasing this
announcement
+44 (0) 20 7399 2760
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBDGDULDBDGGX
(END) Dow Jones Newswires
May 13, 2020 08:28 ET (12:28 GMT)
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Apr 2023 a Apr 2024